Protein kinase C‐mediated inhibition of transmembrane signalling through CCKA and CCKB receptors

1 The rat CCKA and CCKB receptors were stably expressed in Chinese hamster ovary (CHO‐09) cells in order to compare modes of signal transduction and effects of protein kinase C (PKC) thereupon. 2 Spectrofluorophotometry of Fura‐2‐loaded cells revealed that both receptors retained their pharmacologic...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of pharmacology Vol. 123; no. 6; pp. 1189 - 1197
Main Authors Smeets, R L L., Fouraux, M A., Emst‐de Vries, S E., De Pont, J J H H M., Willems, P H G M.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.03.1998
Nature Publishing
Subjects
Online AccessGet full text

Cover

Loading…
Abstract 1 The rat CCKA and CCKB receptors were stably expressed in Chinese hamster ovary (CHO‐09) cells in order to compare modes of signal transduction and effects of protein kinase C (PKC) thereupon. 2 Spectrofluorophotometry of Fura‐2‐loaded cells revealed that both receptors retained their pharmacological characteristics following expression in CHO cells. Sulphated cholecystokinin‐(26‐33)‐peptide amide (CCK‐8‐S) increased the cytosolic Ca2+ concentration ([Ca2+]i) in CCKA cells, measured as an increase in Fura‐2 fluorescence emission ratio, 1000 fold more potently than its non‐sulphated form (CCK‐8‐NS) (EC50 values of 0.19 nM and 0.18 μM, respectively). By contrast, CCK‐8‐S and CCK‐8‐NS were equally potent in CCKB cells (EC50 values of 0.86 nM and 1.18 nM, respectively). The CCKA receptor agonist JMV‐180 increased [Ca2+]i only in CCKA cells. Likewise, pentagastrin increased [Ca2+]i only in CCKB cells. Finally, CCK‐8‐S‐induced Ca2+ signalling through the CCKA receptor was most potently inhibited by the CCKA receptor antagonist L364,718, whereas the CCKB receptor antagonist L365,260 was more potent in CCKB cells. 3 Receptor‐mediated activation of adenylyl cyclase was measured in the presence of the inhibitor of cyclic nucleotide phosphodiesterase activity, 3‐isobutyl‐1‐methylxanthine. CCK‐8‐S and, to a lesser extent, CCK‐8‐NS, but not JMV‐180 or pentagastrin, stimulated the accumulation of cyclicAMP in CCKA cells. By contrast, none of these agonists increased cyclicAMP in CCKB cells. 4 Short‐term (3 min) pretreatment with the PKC activator 12‐O‐tetradecanoylphorbol 13‐acetate (TPA) evoked a rightward shift of the dose‐response curve for the Ca2+ mobilizing effect of CCK‐8‐S in both cell lines. In addition, short‐term TPA pretreatment markedly reduced CCK‐8‐S‐induced cyclicAMP accumulation in CCKA cells. In both cases, the inhibitory effect of TPA was abolished by the PKC inhibitors, GF‐109203X and staurosporine, whereas no inhibition was observed with the inactive phorbol ester, 4‐α‐phorbol 12‐myristate 13‐acetate. 5 During prolonged TPA treatment, the cells gradually recovered from phorbol ester inhibition and in the case of CCK‐8‐S‐induced Ca2+ mobilization complete recovery was achieved after 24 h of TPA treatment. Western blot analysis revealed that this recovery was paralleled by down‐regulation of PKC‐α, suggesting the involvement of this PKC isotype in the inhibitory action of TPA. 6 This study demonstrates that following expression in CHO cells (i) both CCKA and CCKB receptors are coupled to Ca2+ mobilization, (ii) only CCKA receptors are coupled to cyclicAMP formation and (iii) with both receptors signalling is inhibited by PKC. British Journal of Pharmacology (1998) 123, 1189–1197; doi:10.1038/sj.bjp.0701713
AbstractList 1 The rat CCKA and CCKB receptors were stably expressed in Chinese hamster ovary (CHO‐09) cells in order to compare modes of signal transduction and effects of protein kinase C (PKC) thereupon. 2 Spectrofluorophotometry of Fura‐2‐loaded cells revealed that both receptors retained their pharmacological characteristics following expression in CHO cells. Sulphated cholecystokinin‐(26‐33)‐peptide amide (CCK‐8‐S) increased the cytosolic Ca2+ concentration ([Ca2+]i) in CCKA cells, measured as an increase in Fura‐2 fluorescence emission ratio, 1000 fold more potently than its non‐sulphated form (CCK‐8‐NS) (EC50 values of 0.19 nM and 0.18 μM, respectively). By contrast, CCK‐8‐S and CCK‐8‐NS were equally potent in CCKB cells (EC50 values of 0.86 nM and 1.18 nM, respectively). The CCKA receptor agonist JMV‐180 increased [Ca2+]i only in CCKA cells. Likewise, pentagastrin increased [Ca2+]i only in CCKB cells. Finally, CCK‐8‐S‐induced Ca2+ signalling through the CCKA receptor was most potently inhibited by the CCKA receptor antagonist L364,718, whereas the CCKB receptor antagonist L365,260 was more potent in CCKB cells. 3 Receptor‐mediated activation of adenylyl cyclase was measured in the presence of the inhibitor of cyclic nucleotide phosphodiesterase activity, 3‐isobutyl‐1‐methylxanthine. CCK‐8‐S and, to a lesser extent, CCK‐8‐NS, but not JMV‐180 or pentagastrin, stimulated the accumulation of cyclicAMP in CCKA cells. By contrast, none of these agonists increased cyclicAMP in CCKB cells. 4 Short‐term (3 min) pretreatment with the PKC activator 12‐O‐tetradecanoylphorbol 13‐acetate (TPA) evoked a rightward shift of the dose‐response curve for the Ca2+ mobilizing effect of CCK‐8‐S in both cell lines. In addition, short‐term TPA pretreatment markedly reduced CCK‐8‐S‐induced cyclicAMP accumulation in CCKA cells. In both cases, the inhibitory effect of TPA was abolished by the PKC inhibitors, GF‐109203X and staurosporine, whereas no inhibition was observed with the inactive phorbol ester, 4‐α‐phorbol 12‐myristate 13‐acetate. 5 During prolonged TPA treatment, the cells gradually recovered from phorbol ester inhibition and in the case of CCK‐8‐S‐induced Ca2+ mobilization complete recovery was achieved after 24 h of TPA treatment. Western blot analysis revealed that this recovery was paralleled by down‐regulation of PKC‐α, suggesting the involvement of this PKC isotype in the inhibitory action of TPA. 6 This study demonstrates that following expression in CHO cells (i) both CCKA and CCKB receptors are coupled to Ca2+ mobilization, (ii) only CCKA receptors are coupled to cyclicAMP formation and (iii) with both receptors signalling is inhibited by PKC. British Journal of Pharmacology (1998) 123, 1189–1197; doi:10.1038/sj.bjp.0701713
The rat CCK A and CCK B receptors were stably expressed in Chinese hamster ovary (CHO-09) cells in order to compare modes of signal transduction and effects of protein kinase C (PKC) thereupon. Spectrofluorophotometry of Fura-2-loaded cells revealed that both receptors retained their pharmacological characteristics following expression in CHO cells. Sulphated cholecystokinin-(26-33)-peptide amide (CCK-8-S) increased the cytosolic Ca 2+ concentration ([Ca 2+ ] i ) in CCK A cells, measured as an increase in Fura-2 fluorescence emission ratio, 1000 fold more potently than its non-sulphated form (CCK-8-NS) (EC 50 values of 0.19 n M and 0.18 μ M , respectively). By contrast, CCK-8-S and CCK-8-NS were equally potent in CCK B cells (EC 50 values of 0.86 n M and 1.18 n M , respectively). The CCK A receptor agonist JMV-180 increased [Ca 2+ ] i only in CCK A cells. Likewise, pentagastrin increased [Ca 2+ ] i only in CCK B cells. Finally, CCK-8-S-induced Ca 2+ signalling through the CCK A receptor was most potently inhibited by the CCK A receptor antagonist L364,718, whereas the CCK B receptor antagonist L365,260 was more potent in CCK B cells. Receptor-mediated activation of adenylyl cyclase was measured in the presence of the inhibitor of cyclic nucleotide phosphodiesterase activity, 3-isobutyl-1-methylxanthine. CCK-8-S and, to a lesser extent, CCK-8-NS, but not JMV-180 or pentagastrin, stimulated the accumulation of cyclicAMP in CCK A cells. By contrast, none of these agonists increased cyclicAMP in CCK B cells. Short-term (3 min) pretreatment with the PKC activator 12- O -tetradecanoylphorbol 13-acetate (TPA) evoked a rightward shift of the dose-response curve for the Ca 2+ mobilizing effect of CCK-8-S in both cell lines. In addition, short-term TPA pretreatment markedly reduced CCK-8-S-induced cyclicAMP accumulation in CCK A cells. In both cases, the inhibitory effect of TPA was abolished by the PKC inhibitors, GF-109203X and staurosporine, whereas no inhibition was observed with the inactive phorbol ester, 4-α-phorbol 12-myristate 13-acetate. During prolonged TPA treatment, the cells gradually recovered from phorbol ester inhibition and in the case of CCK-8-S-induced Ca 2+ mobilization complete recovery was achieved after 24 h of TPA treatment. Western blot analysis revealed that this recovery was paralleled by down-regulation of PKC-α, suggesting the involvement of this PKC isotype in the inhibitory action of TPA. This study demonstrates that following expression in CHO cells (i) both CCK A and CCK B receptors are coupled to Ca 2+ mobilization, (ii) only CCK A receptors are coupled to cyclicAMP formation and (iii) with both receptors signalling is inhibited by PKC.
Author Fouraux, M A.
Emst‐de Vries, S E.
Willems, P H G M.
De Pont, J J H H M.
Smeets, R L L.
AuthorAffiliation Department of Biochemistry, University of Nijmegen, The Netherlands
AuthorAffiliation_xml – name: Department of Biochemistry, University of Nijmegen, The Netherlands
Author_xml – sequence: 1
  givenname: R L L.
  surname: Smeets
  fullname: Smeets, R L L.
– sequence: 2
  givenname: M A.
  surname: Fouraux
  fullname: Fouraux, M A.
– sequence: 3
  givenname: S E.
  surname: Emst‐de Vries
  fullname: Emst‐de Vries, S E.
– sequence: 4
  givenname: J J H H M.
  surname: De Pont
  fullname: De Pont, J J H H M.
– sequence: 5
  givenname: P H G M.
  surname: Willems
  fullname: Willems, P H G M.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2197975$$DView record in Pascal Francis
BookMark eNpVkb1OwzAUhS1UBKWwMntgTfGN478FqY34E5XoALPlJHbrkjpRHEBsPALPyJOQigqJ6VzpHH26R-cEjUITLELnQKZAqLyMm2mxaadEEBBAD9AYMsETRiWM0JgQIhIAKY_RSYwbQgZTsCN0pBhTimRjVCy7prc-4BcfTLQ4__782trKm95W2Ie1L3zvm4Abh_vOhLi122JQi6NfBVPXPqxwv-6a19Ua5_nDDJtQ7Y457mxp277p4ik6dKaO9myvE_R8c_2U3yWLx9v7fLZI2pRRkThSVdwQCqXMSlkBU4xzsFSoKkupLJxR3KVOiszZ0kEKVkkqM7AVp5kpOJ2gq19u-1oMFUobho9r3XZ-a7oP3Riv_zvBr_WqedPAOEv5DnCxB5hYmtoNPUsf_wApKKEEG2L0N_bua_vxZwPRu0F03OhhEL0fRM-Xd0yBoD8dNYQB
CODEN BJPCBM
ContentType Journal Article
Copyright 1998 British Pharmacological Society
1998 INIST-CNRS
Copyright 1998, Nature Publishing Group 1998 Nature Publishing Group
Copyright_xml – notice: 1998 British Pharmacological Society
– notice: 1998 INIST-CNRS
– notice: Copyright 1998, Nature Publishing Group 1998 Nature Publishing Group
DBID IQODW
5PM
DOI 10.1038/sj.bjp.0701713
DatabaseName Pascal-Francis
PubMed Central (Full Participant titles)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1476-5381
EndPage 1197
ExternalDocumentID 2197975
BPH5917
Genre article
GroupedDBID ---
.3N
.55
.GJ
05W
0R~
1OC
23N
24P
2WC
31~
33P
36B
3O-
3SF
3V.
4.4
52U
52V
53G
5GY
6J9
7RV
7X7
8-0
8-1
88E
8AO
8FE
8FH
8FI
8FJ
8R4
8R5
8UM
A00
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCUV
ABDBF
ABPVW
ABQWH
ABUWG
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFKRA
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
AOIJS
ATUGU
AZBYB
AZVAB
B0M
BAFTC
BAWUL
BBNVY
BENPR
BFHJK
BHBCM
BHPHI
BKEYQ
BMXJE
BPHCQ
BRXPI
BVXVI
C45
CAG
CCPQU
COF
CS3
DCZOG
DIK
DRFUL
DRMAN
DRSTM
DU5
E3Z
EAD
EAP
EAS
EBC
EBD
EBS
ECV
EJD
EMB
EMK
EMOBN
ENC
ESX
EX3
F5P
FUBAC
FYUFA
G-S
GODZA
GX1
H.X
HCIFZ
HGLYW
HMCUK
HYE
HZ~
J5H
KBYEO
LATKE
LEEKS
LH4
LITHE
LK8
LOXES
LSO
LUTES
LW6
LYRES
M1P
M7P
MEWTI
MK0
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
MY~
N9A
NAPCQ
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P4E
PQQKQ
PROAC
PSQYO
Q.N
Q2X
QB0
RIG
ROL
RPM
RWI
SJN
SUPJJ
SV3
TEORI
TR2
TUS
UKHRP
UPT
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WVDHM
WXSBR
X7M
XV2
Y6R
YHG
ZGI
ZXP
ZZTAW
~8M
~S-
08R
AAJUZ
AAPBV
AAUGY
AAVGM
ABCVL
ABHUG
ABPTK
ABWRO
ACXME
ADAWD
ADDAD
AFVGU
AGJLS
IQODW
ZA5
5PM
ID FETCH-LOGICAL-p2537-f0dd6a031c84c8d1595661e379d4238bfa96f2f874fecf121e983841ed634ab63
IEDL.DBID RPM
ISSN 0007-1188
IngestDate Tue Sep 17 21:27:34 EDT 2024
Sun Oct 29 17:08:20 EDT 2023
Sat Aug 24 00:43:43 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Protein kinase C
Enzyme
Transferases
Rodentia
Phosphorus-oxygen lyases
Cyclic AMP
Lyases
Activation
Gene expression
Adenylate cyclase
Signal transduction
Vertebrata
Mammalia
Animal
Established cell line
Peptidergic receptor
Cholecystokinin
Mechanism of action
Tumor cell
Hamster
Calcium Cations
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-p2537-f0dd6a031c84c8d1595661e379d4238bfa96f2f874fecf121e983841ed634ab63
OpenAccessLink https://europepmc.org/articles/pmc1565266?pdf=render
PMID 9559904
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_1565266
pascalfrancis_primary_2197975
wiley_primary_10_1038_sj_bjp_0701713_BPH5917
PublicationCentury 1900
PublicationDate March 1998
PublicationDateYYYYMMDD 1998-03-01
PublicationDate_xml – month: 03
  year: 1998
  text: March 1998
PublicationDecade 1990
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Basingstoke
PublicationTitle British journal of pharmacology
PublicationYear 1998
Publisher Blackwell Publishing Ltd
Nature Publishing
Publisher_xml – name: Blackwell Publishing Ltd
– name: Nature Publishing
References 1992a; 89
1989; 257
1992; 189
1992; 226
1987; 928
1996; 30
1993
1992b; 89
1984; 802
1971; 121
1995; 18
1993; 268
1990; 265
1993; 264
1993; 265
1997; 325
1993; 316
1993b; 424
1994; 268
1984; 4
1996; 271
1995; 269
1993; 215
1992; 89
1994; 4
1996; 20
1993a; 14
References_xml – volume: 14
  start-page: 145
  year: 1993a
  end-page: 159
  article-title: Dose‐dependent recruitment of pancreatic acinar cells during receptor‐mediated calcium mobilization
  publication-title: Cell Calcium
– volume: 89
  start-page: 8691
  year: 1992b
  end-page: 8695
  article-title: Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
– volume: 89
  start-page: 3605
  year: 1992
  end-page: 3609
  article-title: Expression, cloning and characterization of the canine parietal cell gastrin receptor
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
– volume: 265
  start-page: G999
  year: 1993
  end-page: G1004
  article-title: A cloned Cck‐A receptor transduces multiple signals in response to full and partial agonists
  publication-title: Am. J. Physiol.
– volume: 20
  start-page: 1
  year: 1996
  end-page: 9
  article-title: Recovery from Tpa inhibition of receptor‐mediated Ca mobilization is paralleled by down‐regulation of protein kinase C‐α in Cho cells expressing the Cck‐A receptor
  publication-title: Cell Calcium
– volume: 424
  start-page: 171
  year: 1993b
  end-page: 182
  article-title: Receptor‐evoked Ca mobilization in pancreatic acinar cells: evidence for a regulatory role of protein kinase C by a mechanism involving the transition of high‐affinity receptors to a low‐affinity state
  publication-title: Pflügers Arch.
– volume: 268
  start-page: 29
  year: 1994
  end-page: 41
  article-title: Molecular and pharmacological characterization of the human Cck receptor
  publication-title: Eur. J. Pharmacol.
– volume: 30
  start-page: 359
  year: 1996
  end-page: 363
  article-title: Pharmacological characterization of a Chinese hamster ovary cell line transfected with the human Cck‐B receptor gene
  publication-title: Neuropeptides
– volume: 257
  start-page: G594
  year: 1989
  end-page: G600
  article-title: A new Cck analogue differentiates two functionally distinct Cck receptors in rat and mouse pancreatic acini
  publication-title: Am. J. Physiol.
– volume: 121
  start-page: 561
  year: 1971
  end-page: 562
  article-title: A simple and sensitive saturation assay method for the measurement of adenosine 3′:5′‐cyclic monophosphate
  publication-title: Biochem. J.
– volume: 269
  start-page: G628
  year: 1995
  end-page: G646
  article-title: Cholecystokinin receptors
  publication-title: Am. J. Physiol.
– volume: 802
  start-page: 209
  year: 1984
  end-page: 214
  article-title: Potentiating role of cyclicAMP in pancreatic enzyme secretion, demonstrated by means of forskolin
  publication-title: Biochim. Biophys. Acta
– volume: 265
  start-page: 6247
  year: 1990
  end-page: 6254
  article-title: Two functionally distinct cholecystokinin receptors show different modes of actions on Ca mobilization and phospholipid hydrolysis in isolated rat pancreatic acini
  publication-title: J. Biol. Chem.
– volume: 268
  start-page: 23219
  year: 1993
  end-page: 23221
  article-title: Calcium oscillations in pancreatic acinar cells, evoked by the cholecystokinin analogue Jmv‐180, depend on functional inositol 1,4,5‐trisphosphate receptors
  publication-title: J. Biol. Chem.
– start-page: 151
  year: 1993
  end-page: 166
– start-page: 167
  year: 1993
  end-page: 189
– volume: 226
  start-page: 35
  year: 1992
  end-page: 41
  article-title: Pharmacological studies on Cck‐B receptors in guinea pig synaptoneuro‐somes
  publication-title: Eur. J. Pharmacol.
– volume: 4
  start-page: 307
  year: 1994
  end-page: 316
  article-title: Cholecystokinin increases intracellular calcium concentration in native Cho‐K1 cells through the activation of Cck‐A receptors
  publication-title: Pharmacol. Commun.
– volume: 325
  start-page: 93
  year: 1997
  end-page: 99
  article-title: Mutational analysis of the putative devazepide binding site of the Cck receptor
  publication-title: Eur. J. Pharmacol.
– volume: 89
  start-page: 3125
  year: 1992a
  end-page: 3129
  article-title: Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
– volume: 316
  start-page: 48
  year: 1993
  end-page: 52
  article-title: Characterization of cAMP‐dependent protein kinase activation by Cck in rat pancreas
  publication-title: FEBS Lett.
– volume: 215
  start-page: 513
  year: 1993
  end-page: 529
  article-title: The peripheral cholecystokinin receptors
  publication-title: Eur. J. Biochem.
– volume: 189
  start-page: 296
  year: 1992
  end-page: 303
  article-title: Molecular cloning of the human brain and gastric cholecystokinin receptor: structure, functional expression and chromosomal localization
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 928
  start-page: 179
  year: 1987
  end-page: 185
  article-title: Pertussis toxin stimulates cholecystokinin‐induced cyclicAMP formation but is without effect on secretagogue‐induced calcium mobilization in exocrine pancreas
  publication-title: Biochim. Biophys. Acta
– volume: 264
  start-page: G840
  year: 1993
  end-page: G847
  article-title: Multiple kinases phosphorylate the pancreatic cholecystokinin receptor in an agonist‐dependent manner
  publication-title: Am. J. Physiol.
– volume: 271
  start-page: 3750
  year: 1996
  end-page: 3755
  article-title: Phosphorylation of cholecystokinin receptors expressed on Chinese hamster ovary cells
  publication-title: J. Biol. Chem.
– volume: 4
  start-page: 1021
  year: 1984
  end-page: 1033
  article-title: Cholecystokinin receptors: Biochemical demonstration and autoradiographic localization in rat brain and pancreas using [ H]‐cholecystokinin‐8 as radioligand
  publication-title: J. Neurosci.
– volume: 18
  start-page: 471
  year: 1995
  end-page: 483
  article-title: Protein kinase C activation inhibits receptor‐evoked inositol trisphosphate formation and induction of cytosolic calcium oscillations by decreasing the affinity‐state of the cholecystokinin receptor in pancreatic acinar cells
  publication-title: Cell Calcium
SSID ssj0014775
Score 1.6349245
Snippet 1 The rat CCKA and CCKB receptors were stably expressed in Chinese hamster ovary (CHO‐09) cells in order to compare modes of signal transduction and effects of...
The rat CCK A and CCK B receptors were stably expressed in Chinese hamster ovary (CHO-09) cells in order to compare modes of signal transduction and effects of...
SourceID pubmedcentral
pascalfrancis
wiley
SourceType Open Access Repository
Index Database
Publisher
StartPage 1189
SubjectTerms Biological and medical sciences
calcium mobilization
CCK‐8
Cell physiology
Chinese hamster ovary cells
CholecystokininA receptor
cholecystokininB receptor
cyclicAMP formation
Fundamental and applied biological sciences. Psychology
JMV‐180
Medical sciences
Molecular and cellular biology
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems
Pharmacology. Drug treatments
protein kinase C down‐regulation
Signal transduction
TPA
Title Protein kinase C‐mediated inhibition of transmembrane signalling through CCKA and CCKB receptors
URI https://onlinelibrary.wiley.com/doi/abs/10.1038%2Fsj.bjp.0701713
https://pubmed.ncbi.nlm.nih.gov/PMC1565266
Volume 123
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZJoBAopU-6bRN0KDmtd1fW08fENGwbUnxIIDdXLxNvuorpbg_59x3JdtKlt94MwsjMjGa-sWa-QeizKaTncKAzzzXLWJ77zFAByQrYj1PaOipi7_Dld7G8Zt9u-M0e4mMvTCrat6adhZ_rWWhvU21lt7bzsU5sXl2WkHNwCCzzfbQvKR1T9OHqgEnZjy2I7IdEqZGpkar5ZjUzq24GVk4gNztEzyL9WhFntD3v9AZk0vTDLP4tkPwbuKbIc_4SvRggIz7tP-0V2vPhNTqpes7phym-emqh2kzxCa6e2Kgf3qAfVWRiaAO-awNELFxmqVkEgCZuw21rUskWvm_wNkattV9D-hw8jnUdOvF142GUDy7Li1Osg4sPZxg8pe_iqJ636Pr8y1W5zIaxClmXcyqzZuGc0HCYrWJWOcAzAOmIp7JwgK2UaXQhmrxRkjXeNiQnvlBUMeKdoEwbQd-hg3Af_HuEc8O9JE6D17Qs_hAhQmpihfOw08LqCTraEWzd9RQaNfhJWUg-QXJH0I_rkfR6dwVsIZFfD7qfoGlSyeMb6TKdqnqzqkHH9aDj-qxacshIP_z3Rh_R4diGuCCf0MH2129_BDhka44BgX-9OE7W9wfrr-BK
link.rule.ids 230,315,733,786,790,891,27957,27958,53827,53829
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIkSlijdigYIPqKdNdp2XnWMbUS20W-1hi3oLfkXNlnWj7vZQfj1jJ2lZOMEtkhU5yYw938TffAPwSebMpLigA5OKJEiiyAQyzjBZQf_RXCgdZ652eHqaTc6Sr-fp-RakfS2MJ-0rWYf2xzK09YXnVjZLNep5YqPZtMCcI8XAMnoAD3G9RqxP0rvDg4SxtnGB0z-knPdajTEfrRahXDQh-jnF7GwHHjkBttx1adttxAq_StW2s_ibIvk7dPWx5-gpfOufuqWcXIY3axmqn38IOv7zaz2DJx0aJQft8HPYMvYF7M9aOevbIZnfV2ethmSfzO6Frm9fwveZE3moLbmsLQZDUgS-DgUxLKntRS09G4xcVWTtAuLSLDEzt4Y4yojwUuCk6xJEiuL4gAir3cUhwU3YNK4L0Cs4O_o8LyZB17EhaKI0ZkE11joTuE8oniiuESohWqQmZrlG2MZlJfKsiirOksqoikbU5DzmCTU6ixMhs_g1bNsra94AiWRqGNUCDawS96-FZkxQlWmDM42VGMDehsXKplXnKHELZjlLB8A2LHg37vS0N0fQHl5Xu_v-Axh6W9_d4c_pY16uFiU6T9k5T3k4m6SY7L7974k-wuPJfHpSnnw5PX4HO32145i-h-319Y3ZQ7izlh-8c_8CLwwBVw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELZaqlZIFX2LbaH1oeK0SdZ52TlC2tW2FJQDSKiX1E-RhTVRdznQX9-xkwDb3rhFcqI8Zuz5Jp75PoQ-i4LqDCZ0oDOeBmkc60AkOSQr4D-KcamS3PUOHx3ns9P0-1l2dk_qyxftS9GE9nIR2ubc11a2CxkNdWJRdVRCzpFBYIlaZaLH6AnM2bgYEvV-AyGltBMvcByIhLGBrzFh0XIeinkbgq8TyNA20VNHwlY4pbbnLV_ClzGdpMX_ZZL34auPP9MX6Ofw5F3ZyUV4vRKh_PMPqeODXu0l2upRKd7vTnmFHmn7Gu1VHa31zRif3HVpLcd4D1d3hNc3b9CvypE9NBZfNBaCIi4D348CWBY39rwRvioMXxm8coFxoReQoVuNXekI95TguFcLwmV5uI-5Ve7gAMNirFunBvQWnU6_npSzoFduCNo4S2hgJkrlHNYLyVLJFEAmQI1EJ7RQAN-YMLzITWwYTY2WhsREFyxhKdEqT1Iu8uQd2rBXVm8jHItMU6I4GFmm7p8LySknMlca7jSRfIR216xWtx1LRw1LMS1oNkJ0zYq3445Xe30EbOL5tXsbjNDY2_v2Cr9fn7B6Oa_BgeregeqDapZB0vv-wTf6hJ5VX6b1j2_Hhx_Q5tD0OCE7aGP1-1rvAupZiY_ev_8CPHwD1w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Protein+kinase+C-mediated+inhibition+of+transmembrane+signalling+through+CCKA+and+CCKB+receptors&rft.jtitle=British+journal+of+pharmacology&rft.au=Smeets%2C+R+L+L&rft.au=Fouraux%2C+M+A&rft.au=van+Emst-de+Vries%2C+S+E&rft.au=De+Pont%2C+J+J+H+H+M&rft.date=1998-03-01&rft.issn=0007-1188&rft.volume=123&rft.issue=6&rft.spage=1189&rft.epage=1197&rft_id=info:doi/10.1038%2Fsj.bjp.0701713&rft_id=info%3Apmid%2F9559904&rft.externalDBID=PMC1565266
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1188&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1188&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1188&client=summon